Axa parenterals Ltd. is WHO-GMP accredited company designed as per US USFDA & EU guidelines to comply with regulated market. Approaching to the African and CIC countries and well stablished in south East Asian nations. We act in a comprehensive regulatory framework for prescription with an ultra modernized plant well equipped with modern technology, having a land area of 1,45,000 sq. feet and constructed area of 2,80,000 sq. feet in two floors, We have emerged as leader across all its business and have established a footprint with customers. The company is presently capable of producing 50 million bottles per annum of 100 ml to 500 ml, and other 50 million vials of 5ml, 10 ml, 20 ml & 30 ml sizes.